Vertical: CNMBase Year: 2025
Market Size (2025)
$607.00M
Projected (2032)
$868.30M
CAGR (2022–2032)
5.3%
Key Players
11+
Market Overview
The Global Feed Enzymes Market was valued at USD 607.00 Million in 2025 and is projected to reach USD 868.30 Million by 2032, expanding at a CAGR of 5.25% during 2026–2032. The market has grown steadily from USD 520.49 Million in 2022, and the forecast period is expected to add a further USD 261.30 Million in absolute value between 2025 and 2032. Feed enzymes have moved from being an optional performance additive to a standard component of compound feed formulation for poultry and swine, because they allow nutritionists to lower diet cost, replace inorganic phosphate, use a wider range of cereals and by-products, and reduce nutrient excretion.
Growth over the forecast period is underpinned by three structural forces. First, global demand for animal protein continues to rise, led by poultry meat, which increases compound feed volumes. Second, volatile prices of feed grains, soybean meal and feed phosphates keep the economic case for enzyme-led reformulation strong. Third, regulation on antibiotic growth promoters and on nutrient pollution in major producing regions encourages feed strategies that improve digestibility and gut health. These forces are partly offset by the high penetration already achieved by phytase in mature markets, by price competition among suppliers, and by the regulatory time and cost required to register new enzyme products.
Key Findings
By Enzyme Type: Phytase is the largest segment with USD 333.85 Million in 2025 (55.0% share), while Proteases is the fastest-growing segment at a CAGR of 7.52% during 2026–2032.
By Livestock: Poultry leads with USD 333.85 Million in 2025 (55.0% share). The Others segment is the fastest-growing, at a CAGR of 6.07%.
By Physical Form: Dry enzymes account for USD 455.25 Million in 2025 (75.0% share), whereas Liquid enzymes register the higher CAGR of 6.69%.
By Region: Asia Pacific is both the leading region, with USD 230.66 Million in 2025 (38.0% share), and the fastest-growing region, at a CAGR of 6.13%. North America and Europe each account for USD 133.54 Million (22.0% share) in 2025.
By Country: China is the leading country market at USD 110.72 Million in 2025, and India is the fastest-growing country, at a CAGR of 9.00% during 2026–2032.
Segmentation Summary
The market is analysed by enzyme type (Phytase, Carbohydrases and Proteases), by livestock (Poultry, Swine and Others) and by physical form (Dry and Liquid), across five regions and their constituent countries. Phytase remains the anchor product of the industry, but its share is expected to ease from 55.0% in 2025 to 51.6% in 2032 as Carbohydrases and Proteases grow faster on the back of non-starch polysaccharide (NSP) management and reduced-protein diet strategies. Poultry accounts for the majority of demand, reflecting the scale of broiler and layer feed production and the near-universal use of enzymes in commercial poultry diets. Dry formulations dominate because most enzyme products are dosed into mash or pelleted feed through premixes, while liquid enzymes gain share through post-pelleting application at larger feed mills.
Competitive Landscape Summary
The market is moderately consolidated. A small group of biotechnology and nutrition companies with proprietary enzyme strains, fermentation capacity and global registration portfolios, namely Novonesis, IFF (Danisco Animal Nutrition & Health), AB Vista and BASF, holds a leading position, supported by challengers such as Adisseo, Huvepharma and Novus International, and by niche and regional specialists including Kemin Industries, Alltech, Advanced Enzyme Technologies and Qingdao Vland Biotech. The structure of the industry changed materially in June 2025, when Novonesis completed the acquisition of dsm-firmenich's share of the long-standing Feed Enzyme Alliance and took direct control of sales and distribution. Competition centres on next-generation phytases, multi-enzyme blends, thermostability, regional registrations and technical service.
Challenges and Opportunities
The principal challenges are the maturity of phytase in developed markets, persistent price pressure from Chinese and Indian producers, the cost and duration of product registration, and the volatility of livestock production caused by animal disease outbreaks and feed-cost cycles. Opportunities lie in the expansion of commercial poultry production in Asia Pacific, Latin America and the Middle East & Africa, in reduced-soybean-meal and alternative-ingredient diets that require NSP enzymes and proteases, in enzyme applications for ruminants and aquaculture, and in combined enzyme–probiotic solutions that address both nutrient digestibility and gut health.
Future Outlook
The market is expected to grow at a CAGR of 5.25% during 2026–2032, with Asia Pacific contributing the largest increment of value (USD 120.13 Million between 2025 and 2032). Product innovation is expected to concentrate on higher-efficacy phytases capable of replacing inorganic phosphate, on proteases that support lower crude-protein diets, and on species-specific solutions for dairy cattle and fish. Suppliers that combine strain development, fermentation scale, regulatory capability and on-farm technical service are best placed to capture this growth.
The Feed Enzymes Market market is projected to grow at a CAGR of 5.3% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
Feed enzymes are exogenous, biologically active proteins added to animal feed to hydrolyse specific substrates that the animal cannot digest efficiently with its own enzymes, or that act as anti-nutritional factors. They are produced mainly by submerged or solid-state microbial fermentation using bacterial, fungal or yeast production strains, and are then stabilised, formulated and standardised to a guaranteed activity level. In the European Union, enzymes are authorised as zootechnical additives within the functional group of digestibility enhancers under Regulation (EC) No 1831/2003.
The principal enzyme classes are phytases, which hydrolyse phytic acid and release phytate-bound phosphorus, calcium and other nutrients; carbohydrases, including xylanases, β-glucanases, β-mannanases, α-amylases and α-galactosidases, which degrade non-starch polysaccharides and starch; and proteases, which hydrolyse dietary proteins and protein-based anti-nutritional factors.
Included in the scope: commercial phytase, carbohydrase and protease products, single-enzyme and multi-enzyme, supplied in dry (powder, granulated and coated) or liquid form to feed mills, premix manufacturers, integrators and livestock producers for poultry, swine and other species. Excluded from the scope: enzymes used in food processing, biofuels, textiles and other industrial applications; direct-fed microbials and probiotics sold without an enzyme component; silage inoculants; and veterinary medicinal products. The market is valued at the manufacturer and supplier level in USD Million.
Scope of the Study
The study quantifies the market for the historic period 2022–2024, the base year 2025 and the forecast period 2026–2032. All values are expressed in USD Million, and growth rates refer to the compound annual growth rate for 2026–2032. The market is segmented as follows:
By Enzyme Type: Phytase, Carbohydrases, Proteases
By Livestock: Poultry, Swine, Others
By Physical Form: Dry, Liquid
By Region: North America, Europe, Asia Pacific, Latin America, Middle East & Africa
By Country: U.S., Canada, Mexico; Germany, U.K., France, Italy, Spain, Rest of Europe; China, India, Japan, Rest of Asia Pacific; Brazil, Argentina, Rest of Latin America; UAE, Saudi Arabia, South Africa, Rest of MEA
Research Objectives
To estimate the size of the global feed enzymes market for 2022–2025 and to forecast it to 2032 in USD Million.
To analyse the market by enzyme type, livestock and physical form, and to identify the largest and fastest-growing segments.
To assess the market across five regions and twenty country-level markets, including country-wise segmentation.
To evaluate the role of phosphorus, energy and amino acid matrix values in the economics of enzyme use in poultry and swine diets.
To examine the influence of antibiotic growth promoter restrictions, feed additive authorisation rules and nutrient-pollution regulation on enzyme demand.
To identify the drivers, restraints, opportunities, trends and challenges that shape the market over 2026–2032.
To profile the competitive structure of the market, including positioning, competitive strengths and key developments since 2022.
To identify growth opportunities in emerging applications such as ruminant and aquaculture feed, liquid post-pellet application and enzyme–probiotic combinations.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study follows a structured research process that combines extensive secondary research, primary research with participants across the feed enzyme value chain, and quantitative modelling. The process moves through four stages: (1) definition of the market, its scope and segmentation; (2) collection of secondary data on livestock production, compound feed output, enzyme inclusion practices, company activity and regulation; (3) validation and refinement of the data through primary interviews; and (4) estimation and forecasting of the market using top-down and bottom-up approaches, followed by data triangulation and internal quality review.
Secondary Research
Secondary research was used to build the baseline understanding of the market, to collect historic data and to identify participants. The main source types were:
Industry associations: feed manufacturers' and feed additive associations at global and national level, such as the International Feed Industry Federation (IFIF), FEFAC in Europe, the American Feed Industry Association (AFIA), and national poultry and pork producer bodies.
Government and regulatory bodies: the Food and Agriculture Organization (FAO), the U.S. Department of Agriculture, the U.S. Food and Drug Administration Center for Veterinary Medicine, the European Food Safety Authority (EFSA) and the European Commission, China's Ministry of Agriculture and Rural Affairs, Brazil's Ministry of Agriculture and Livestock, and the Canadian Food Inspection Agency.
Company filings: annual reports, investor presentations, interim results and press releases of enzyme producers and animal nutrition companies.
Trade journals and technical literature: animal nutrition and feed industry publications, peer-reviewed journals on poultry and swine nutrition, and published enzyme efficacy studies.
Paid and statistical databases: trade, production and financial databases, including livestock and compound feed production statistics, used to establish demand-side volumes.
Primary Research
Primary research was conducted to validate the secondary findings, to fill data gaps and to obtain qualitative insight into market trends. Interviews were held with participants on both the supply side and the demand side of the market.
Supply-side respondents: product managers, technical service managers, regional sales heads and business development executives of enzyme manufacturers, formulators and distributors.
Demand-side respondents: nutritionists and procurement managers at compound feed mills, premix companies and integrated poultry and swine producers, as well as independent animal nutrition consultants.
Objectives: to validate market size and segment splits, to understand inclusion rates and pricing, to assess adoption of new-generation phytases, liquid application and multi-enzyme products, and to gauge the competitive position of key suppliers.
Market Size Estimation
Top-down approach: the overall market was estimated from the value of the global feed additives market and the proportion attributable to feed enzymes, and then allocated to regions, countries and segments using secondary data and primary insight on product mix and adoption.
Bottom-up approach: the market was built from compound feed production by species and country, multiplied by the share of feed treated with each enzyme class, the average inclusion rate and the average selling price. Country estimates were aggregated to regional and global totals.
Data triangulation: the results of the two approaches were compared and reconciled. Differences were resolved by weighting the more reliable data points and by validation with primary respondents, so that the final estimates are consistent across segments, regions and countries.
Forecasting Methodology
The forecast was developed by projecting the base-year market using growth factors for each segment, region and country. The factors considered include livestock and compound feed production growth, enzyme penetration and inclusion rates, the replacement of inorganic phosphate, feed raw material prices, the regulatory environment for antibiotic growth promoters and feed additives, product innovation, and average selling price trends. Each factor was assessed for its direction and strength over the short, medium and long term, and the results were reviewed against the opinions of industry participants.
Base Year, Forecast Period and Currency
Historic years: 2022, 2023 and 2024
Base year: 2025
Forecast period: 2026–2032
CAGR period: 2026–2032
Currency and unit: USD Million
Assumptions and Limitations
Exchange rates are held at constant base-year levels over the forecast period, so values do not reflect currency movements.
No major disruption to global feed and livestock trade is assumed beyond normal cyclical variation; animal disease outbreaks are assumed to follow historical patterns.
Existing regulations on feed additives, antibiotic use and nutrient emissions are assumed to remain in force, with no reversal of current restrictions.
Average selling prices are assumed to decline gradually in mature segments because of competition, partly offset by the introduction of premium, higher-efficacy products.
Revenue of private companies is not publicly reported, so their positioning is assessed qualitatively; market estimates rely on triangulation rather than on company-level disclosures.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The global feed enzymes market is moderately consolidated. A limited number of companies with proprietary production strains, large-scale fermentation capacity, broad product registrations and global technical service networks account for a substantial portion of the market, while a wider group of regional producers, particularly in China and India, competes mainly on price in standard phytase and carbohydrase products. Competition is based on product efficacy and the matrix values that suppliers can support with trial data, thermostability and suitability for pelleted and liquid application, the breadth of species registrations, price per unit of activity, and the quality of technical and analytical services provided to nutritionists.
The structure of the market has changed significantly since 2022. Novozymes and Chr. Hansen merged to form Novonesis in January 2024, and in June 2025 Novonesis completed the acquisition of dsm-firmenich's share of the Feed Enzyme Alliance, the partnership through which the two companies had jointly developed and marketed feed enzymes for more than 25 years; Novonesis now controls research, production, sales and distribution, while dsm-firmenich buys enzymes for its premix business. Other suppliers have strengthened their positions through acquisitions, such as Novus International's purchases of Agrivida and BioResource International and Kemin Industries' acquisition of CJ Youtell Biotech, and through new product approvals in the European Union and region-specific launches in Asia and Latin America.
Key Player Positioning
Based on product portfolio breadth, technological capability, geographic reach and market presence, the leading companies profiled in this study are positioned as follows.
Market Leaders
Novonesis (Denmark): a biosolutions company formed by the merger of Novozymes and Chr. Hansen, with sales of EUR 4,157.6 million in FY2025. Its feed enzyme portfolio includes HiPhorius and Ronozyme HiPhos phytases, ProAct 360 protease and the Ronozyme range of carbohydrases. Since June 2025 it has controlled the full feed enzyme value chain previously run through the alliance with dsm-firmenich.
IFF – Danisco Animal Nutrition & Health (USA): part of International Flavors & Fragrances, which reported net sales of USD 10.89 billion in FY2025. Its portfolio includes Axtra PHY GOLD and Phyzyme XP phytases, Axtra XB and Axtra XAP multi-enzymes, Axtra PRO protease and the Syncra enzyme–probiotic range, and it launched a dairy phytase in 2026.
AB Vista (UK): the feed additive business of AB Agri, part of Associated British Foods, which reported revenue of GBP 19,459 million in FY2025 (Agriculture segment GBP 1,616 million). It is a phytase specialist with Quantum Blue phytase, the Econase xylanase range and the Signis stimbiotic, supported by laboratory and feed-quality services.
BASF SE (Germany): a diversified chemical group with sales of EUR 59.7 billion in FY2025 (Nutrition & Care segment EUR 6,509 million). It produces Natuphos and Natuphos E phytases, Natugrain TS and Natupulse TS in Germany and co-develops and distributes feed enzymes with Cargill in the Americas, Iberia and the Middle East & Africa.
Challengers
Adisseo (France): an animal nutrition company majority-owned by Bluestar Adisseo, which reported revenue of RMB 17,231 million in FY2025. Its Rovabio range of NSP enzymes and the Rovabio PhyPlus phytase complement its methionine and specialty additive business.
Huvepharma (Bulgaria): a privately held animal health and nutrition company (revenue not publicly disclosed) with in-house fermentation and the OptiPhos phytase and Hostazym xylanase product lines, sold in more than 90 countries.
Novus International (USA): a privately held company (revenue not publicly disclosed) owned by Mitsui & Co. and Nippon Soda, offering CIBENZA and Versazyme proteases, Xylamax xylanase, Dymanase mannanase and Phytamax phytase following its acquisitions of Agrivida (2023) and BioResource International (2024).
Niche and Regional Players
Kemin Industries (USA): a privately held, family-owned ingredient manufacturer (revenue not publicly disclosed) offering the Kemzyme range of feed enzymes, which expanded its enzyme fermentation base in China through the acquisition of CJ Youtell Biotech in 2025.
Alltech (USA): a privately held animal nutrition company (revenue not publicly disclosed) that produces enzymes by solid-state fermentation, including the Allzyme SSF multi-enzyme complex, as part of a broad natural feed additive portfolio.
Advanced Enzyme Technologies (India): a listed specialty enzyme producer with consolidated revenue from operations of INR 7,458 million in FY2026 (year ended March 2026), including INR 946 million from animal nutrition, offering the DigeGrain and DigePhos ranges in dry and liquid forms.
Qingdao Vland Biotech (China): a Shanghai-listed producer of feed, food and industrial enzymes, probiotics and animal health products, with revenue of CNY 1,366 million in FY2025, focused mainly on the Chinese market.
Threat of New Entrants: Low
Proprietary strains, patents and protein engineering capability create high technological barriers.
Product registration in the EU, United States, China and Brazil requires extensive dossiers, efficacy trials and time.
Large-scale fermentation capacity and global technical service networks require significant capital investment.
Bargaining Power of Suppliers: Low
Fermentation substrates and formulation materials are widely available commodities with many suppliers.
Leading enzyme producers own their strains and fermentation assets, which limits dependence on external suppliers.
Bargaining Power of Buyers: High
Large integrators and multinational feed companies purchase in high volumes and run competitive tenders.
Standard phytase and xylanase products are well understood, allowing buyers to compare offers on cost per unit of activity.
Buyers can switch suppliers after in-house trials, which places continuous pressure on prices.
Threat of Substitutes: Low
No alternative technology matches phytase in releasing phytate-bound phosphorus at comparable cost.
Inorganic phosphates and higher-quality raw materials can partly substitute for enzyme use, but at higher diet cost.
Other gut-health additives such as probiotics and organic acids are generally complementary to enzymes.
Intensity of Competitive Rivalry: High
A small number of global suppliers compete closely on efficacy claims, matrix values and price.
Low-cost producers from China and India intensify price competition in standard products.
Suppliers compete through new product launches, regional registrations and acquisitions.
Threat of New Entrants: Low; Strain technology, patents, registration and fermentation scale.
Bargaining Power of Suppliers: Low; Commodity inputs and producer-owned strains and plants.
Bargaining Power of Buyers: High; Concentrated, high-volume buyers able to switch after trials.
Threat of Substitutes: Low; No cost-effective alternative to phytase; other additives complementary.
Competitive Rivalry: High; Few global players, active low-cost competition, continuous launches.
Market estimates by geography (2032)
InsightAsia Pacific leads with $350.79M by 2032, while Middle East & Africa is projected to grow fastest at a 6.3% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $118.67M | $145.09M | $181.47M | 4.3% | 21% |
| Europe | $121.79M | $143.07M | $175.40M | 3.7% | 20% |
| Asia Pacific | $190.50M | $260.97M | $350.79M | 6.3% | 40% |
| Latin America | $65.58M | $88.70M | $116.35M | 5.9% | 13% |
| Middle East & Africa | $23.94M | $34.61M | $44.28M | 6.3% | 5% |
| Total | $520.49M | $672.44M | $868.30M | 5.3% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$868.30M
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Phytase | $448.04M | 4.2% | 52% |
| Carbohydrases | $317.80M | 6.0% | 37% |
| Proteases | $102.46M | 8.6% | 12% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Feed Enzymes Market covering market dynamics, competitive landscape, and strategic outlook.
The Feed Enzymes Market market is projected to reach $868.30M by 2032, growing at 5.3% CAGR. The Phytase segment holds the largest share.
The Global Feed Enzymes Market is shaped by the economics of feed formulation, the growth of global livestock production and the regulatory environment for feed additives, antibiotics and nutrient emissions. Enzymes deliver value by allowing nutritionists to assign nutrient matrix values to phosphorus, calcium, energy and amino acids, which reduces diet cost at a given level of animal performance. This section assesses the factors that promote and inhibit market growth over 2026–2032. The growth factor analysis in Section 4.2 rates five macro factors and five micro factors by impact type and by an impact score out of 10 for three time periods; these scores are analyst assessments based on secondary research and discussions with industry participants, with higher scores indicating a stronger influence on the market.
Rising Demand for Animal Protein and Compound Feed
Growth in population and incomes continues to raise consumption of meat, eggs, milk and fish, and this translates directly into higher compound feed output. The OECD-FAO Agricultural Outlook 2026–2035 projects global meat consumption to reach about 412 million tonnes by 2035, an increase of around 12% over the 2023–2025 base, with poultry meat contributing the largest increase of roughly 29 million tonnes. Industry surveys show that global feed production reached about 1.44 billion tonnes in 2025, with broiler and pig feed the two largest categories at around 400 million tonnes and 381 million tonnes respectively. Because enzyme use is already standard in most commercial poultry and swine diets, every incremental tonne of compound feed creates additional enzyme demand. The shift from backyard to commercial, integrated production in Asia, Latin America and Africa reinforces this effect, since commercial producers formulate least-cost diets and rely on additives to maintain performance. Poultry is the main beneficiary of this trend because of its short production cycle, favourable feed conversion and broad cultural acceptance, which explains why the Poultry segment holds the largest share of the market and grows faster than Swine over the forecast period.
Feed Cost Pressure and Replacement of Inorganic Phosphate
Feed accounts for the largest share of the cost of producing poultry meat, eggs and pork, so integrators and feed mills continuously seek ways to lower diet cost. Phytase allows nutritionists to release the phosphorus stored as phytate in cereals and oilseed meals and to reduce or remove inorganic feed phosphates such as dicalcium and monocalcium phosphate from the diet. Next-generation phytases, used at higher dose rates in so-called superdosing strategies, further break down phytate and improve the availability of calcium, energy and amino acids. Carbohydrases and proteases add further matrix values for energy and digestible amino acids, enabling the use of cheaper or more variable raw materials such as wheat, barley, rye, distillers' grains and rapeseed meal. Periods of high grain, soybean meal and phosphate prices strengthen the return on enzyme use, and because enzymes typically cost less than the nutrients they replace, they remain one of the most cost-effective tools available to nutritionists. This economic logic underpins the dominant position of Phytase and the steady expansion of Carbohydrases and Proteases.
Restrictions on Antibiotic Growth Promoters
Regulators in major producing regions have progressively restricted the use of antibiotics to promote growth in livestock, prompting producers to adopt nutritional strategies that support gut health. The European Union banned antibiotic growth promoters from 1 January 2006, and Regulation (EU) 2019/6 on veterinary medicinal products, which applies from 28 January 2022, prohibits antimicrobials for growth promotion and restricts preventive group treatment. China withdrew growth-promoting drug additives from feed under Ministry of Agriculture and Rural Affairs Announcement No. 194, with production of commercial feed containing them ending on 1 July 2020. In the United States, the Veterinary Feed Directive has required veterinary oversight of medically important antimicrobials in feed since 1 January 2017, and FDA Guidance for Industry #263 moved remaining over-the-counter medically important antimicrobials to prescription status in June 2023. Enzymes reduce the amount of undigested substrate, particularly non-starch polysaccharides and protein, that reaches the hindgut and can fuel the growth of harmful bacteria. As a result, xylanases, proteases and enzyme–probiotic combinations are increasingly positioned as part of antibiotic-free production programmes.
Environmental Regulation of Nutrient Excretion
Phosphorus and nitrogen excreted in manure contribute to eutrophication of surface waters, and authorities in regions with intensive livestock production regulate manure application. In the European Union, the Nitrates Directive (91/676/EEC) limits the application of livestock manure to 170 kg of nitrogen per hectare per year in nitrate vulnerable zones, and several member states operate national phosphate rules that cap livestock numbers or manure phosphorus. Published research shows that phytase supplementation can reduce manure phosphorus by roughly 10–56% in broilers and 21–51% in growing-finishing pigs, depending on diet and dose. Proteases support lower crude-protein diets, which reduce nitrogen excretion and ammonia emissions. These benefits allow producers to comply with environmental limits while maintaining herd and flock size, and they align enzyme use with corporate sustainability targets set by food retailers and protein companies. Environmental compliance therefore strengthens the case for enzyme use beyond pure feed cost savings, particularly in Europe, North America and the more densely farmed parts of Asia.
Reduced Soybean Meal and Alternative Ingredient Diets
Efforts to reduce dependence on imported soybean meal create demand for enzymes that improve the digestibility of alternative proteins and fibrous ingredients. China's Ministry of Agriculture and Rural Affairs issued a three-year action plan in April 2023 targeting a reduction of soybean meal in animal feed to below 13% by 2025, from 14.5% in 2022. Diets that include more rapeseed meal, cottonseed meal, distillers' grains and other by-products contain higher levels of NSP and anti-nutritional factors, which increases the value of carbohydrases and proteases. This is a major reason for the higher growth of these segments in Asia Pacific.
Ruminant and Aquaculture Applications
Enzyme use in ruminant and aquaculture feed remains low relative to poultry and swine, offering a significant long-term opportunity. Suppliers have begun to address these species directly; for example, IFF launched a phytase designed for dairy cattle in September 2026, and the HiPhorius phytase was authorised in the European Union for fin fish in 2024. Growth in aquaculture output and in intensive dairy production in Asia and the Middle East supports the higher CAGR of the Others livestock segment.
Enzyme–Probiotic Combinations and Liquid Application
Combined products that pair enzymes with probiotics, and stimbiotic concepts that stimulate fibre-fermenting gut microbiota, allow suppliers to position enzymes as part of gut-health programmes and to command premium prices. At the same time, the growth of large, automated feed mills supports liquid enzyme application after pelleting, which avoids heat losses and permits precise dosing. These developments underpin the faster growth of the Liquid segment.
High Penetration and Price Erosion in Mature Markets
Phytase is used in the large majority of commercial poultry and swine diets in North America and Europe, which limits volume growth in these markets to the rate of feed production growth. Competition between global suppliers and low-cost producers from China and India has also reduced average selling prices for standard phytase and xylanase products. This combination of high penetration and price erosion explains the lower CAGR of Phytase compared with Carbohydrases and Proteases, and the slower growth of Europe and North America compared with emerging regions.
Regulatory Cost and Time to Market
Feed enzymes require product-specific authorisation in most major markets. In the European Union, each enzyme must be assessed by EFSA's FEEDAP Panel and authorised by implementing regulation for named target species, with authorisations valid for ten years and subject to renewal. Similar registration processes apply in China, Brazil and other markets. The dossiers, efficacy trials and timelines involved raise the cost of innovation, delay the introduction of new products and favour large suppliers with dedicated regulatory teams.
Variability of Efficacy Under Field Conditions
Enzyme response depends on diet composition, raw material quality, animal age and feed processing. High conditioning and pelleting temperatures can reduce the activity of less thermostable products, and responses measured in trials are not always reproduced on farm. This variability makes some producers cautious about assigning full matrix values to enzymes, which limits the savings captured and slows the adoption of new products.
Consolidation and Vertical Integration of the Supply Base
The supply side has consolidated. Novozymes and Chr. Hansen merged to form Novonesis in January 2024, and Novonesis completed the acquisition of dsm-firmenich's share of the Feed Enzyme Alliance in June 2025. Novus International acquired Agrivida in 2023 and BioResource International in 2024, and Kemin Industries acquired CJ Youtell Biotech, an enzyme and fermentation business in China, in 2025. Suppliers are integrating fermentation capacity and commercial channels to control cost and customer access.
Next-Generation Phytases and Multi-Enzyme Blends
Product development has shifted towards phytases with faster action and higher heat stability, and towards blends of phytase, xylanase and protease tailored to specific diets and regions. Recent examples include the EU authorisation of Axtra PHY GOLD in 2023 and of Axtra XAP in 2024, the full EU label registration of HiPhorius in 2026, and AB Vista's China-specific blends launched in 2026.
Data-Driven Feed Formulation Services
Enzyme suppliers increasingly differentiate through analytical and advisory services, such as near-infrared analysis of raw materials, phytate and fibre measurement, and digestibility models that help nutritionists assign matrix values with confidence. These services strengthen customer relationships and support the adoption of premium products.
Volatility from Animal Disease Outbreaks
Outbreaks of African swine fever and highly pathogenic avian influenza can sharply reduce animal numbers in affected countries, which lowers feed and enzyme demand for extended periods. This volatility is a persistent challenge for suppliers, particularly in the swine segment, and is reflected in the lower growth rate of Swine compared with Poultry and Others.
The feed enzymes value chain comprises four principal stages, from fermentation inputs through to livestock producers.
Raw materials and inputs: fermentation substrates such as glucose, starch, molasses and soybean or corn-based nutrients; mineral salts; proprietary production strains developed through strain engineering; and formulation materials such as carriers, coatings and stabilisers. Research and development in enzyme discovery and protein engineering sits at the start of the chain and is a key source of competitive advantage.
Manufacturing: submerged or solid-state fermentation, followed by recovery, purification and concentration of the enzyme, and then formulation into granulated, coated, powder or liquid products standardised to guaranteed activity. Thermostable coatings and granulation are critical for products used in pelleted feed. Capacity is concentrated among a limited number of producers with large fermentation sites in Europe, North America and China.
Distribution and channels: enzymes reach the market through direct sales to large integrators and feed mills, through premix and feed additive companies, and through regional distributors. Technical service, including dosing advice and matrix recommendations, is an integral part of the channel.
End users: compound feed manufacturers, integrated poultry and swine producers, premix manufacturers, and to a lesser extent livestock farms that mix their own feed. Poultry and swine producers account for the bulk of demand, with growing use in ruminant and aquaculture feed.
North America
United States: animal food ingredients, including enzymes, are regulated by the U.S. Food and Drug Administration Center for Veterinary Medicine under the Federal Food, Drug, and Cosmetic Act, either as approved food additives or as ingredients that are generally recognised as safe (GRAS) for their intended use. Feed manufacturers are subject to the Current Good Manufacturing Practice and preventive controls requirements for animal food introduced under the Food Safety Modernization Act.
United States, antimicrobial policy: the Veterinary Feed Directive (effective 1 January 2017) and FDA Guidance for Industry #263 (transition completed in June 2023) restrict medically important antimicrobials in feed to veterinary oversight.
Canada: livestock feeds, including enzyme ingredients, are regulated by the Canadian Food Inspection Agency under the Feeds Act and Feeds Regulations, which require evaluation and approval of new feed ingredients.
Europe
Regulation (EC) No 1831/2003 on additives for use in animal nutrition requires pre-market authorisation of every feed additive. Enzymes are classified as zootechnical additives in the functional group of digestibility enhancers, authorised for named target species for ten years, and renewable. The EU Register of Feed Additives lists authorised products.
EFSA FEEDAP Panel assesses the safety and efficacy of each enzyme before the European Commission adopts an implementing regulation.
Regulation (EU) 2019/6 on veterinary medicinal products, applicable from 28 January 2022, prohibits antimicrobials for growth promotion and restricts preventive use.
Nitrates Directive (91/676/EEC) limits manure nitrogen application in nitrate vulnerable zones to 170 kg per hectare per year.
Asia Pacific
China: feed additives are regulated by the Ministry of Agriculture and Rural Affairs under the State Council's Regulations on the Administration of Feed and Feed Additives, with permitted additives listed in the national feed additive catalogue. MARA Announcement No. 194 withdrew growth-promoting drug feed additives from 2020.
China, feed resource policy: the 2023 action plan to reduce soybean meal use in feed targets a share below 13% by 2025.
India: the Government of India prohibited the use of colistin in food-producing animals, poultry and aqua farming and in animal feed supplements in 2019, reinforcing the move away from antibiotic growth promoters.
Latin America
Brazil: the Ministry of Agriculture and Livestock (MAPA) regulates animal feed products, including enzymes, and requires registration of establishments and products in its official system.
Export-oriented producers in Brazil and Argentina align feed additive and antimicrobial practices with the requirements of importing markets, including the European Union's rules under Regulation (EU) 2019/6.
Middle East & Africa
Feed additive registration is administered by national agriculture and food safety authorities, and many countries in the Gulf region and Africa reference EU or Codex standards when approving products.
Food security strategies in Gulf countries support domestic poultry production and compound feed capacity, which increases the need for registered feed additives.
Jan 2023: Novus International; Acquisition; Acquired Agrivida Inc., gaining the INTERIUS in-grain feed additive technology and the GRAINZYME phytase.
Jan 2023: BASF SE; Partnership; Extended its feed enzyme co-development and distribution partnership with Cargill to the United States.
2023: Huvepharma; Expansion; Opened new affiliates in Indonesia and the Philippines to expand its commercial presence in Asia.
Jul 2023: IFF (Danisco Animal Nutrition & Health); Approval / Product Launch; Received EU authorisation for Axtra PHY GOLD phytase for swine and poultry and introduced it in the EU.
Jan 2024: Novonesis; Merger; Novozymes and Chr. Hansen completed their merger, forming Novonesis.
Mar 2024: Novus International; Acquisition; Completed the acquisition of enzyme producer BioResource International, including its products, intellectual property and facilities.
Mar 2024: Huvepharma; Approval; Received renewal and extension of the EU authorisation of its xylanase to additional poultry and pig categories (Regulation (EU) 2024/780).
Apr 2024: Adisseo; Product Launch; Launched the Rovabio PhyPlus thermostable liquid phytase in Brazil, following launches in Mexico (2022) and Argentina (2023).
Jun 2024: IFF (Danisco Animal Nutrition & Health); Approval / Product Launch; Received EU-wide approval for and launched Axtra XAP and Syncra AVI for poultry.
Jun 2024: BASF SE; Approval; Received EU authorisation of its endo-1,4-beta-mannanase for poultry for fattening and ornamental birds (Regulation (EU) 2024/1743).
Sep 2024: Novonesis; Approval; HiPhorius phytase, developed under the Feed Enzyme Alliance, was authorised in the EU for poultry, sows and fin fish.
Feb 2025: Novonesis; Acquisition; Agreed to acquire dsm-firmenich's share of the Feed Enzyme Alliance for EUR 1.5 billion.
Jun 2025: Novonesis; Acquisition; Completed the Feed Enzyme Alliance transaction, taking full control of feed enzyme sales and distribution.
Sep 2025: Kemin Industries; Acquisition; Acquired CJ Youtell Biotech, the enzyme and fermentation subsidiary of CJ Bio, with plants in Shandong and Hunan, China.
Apr 2026: AB Vista; Product Launch; Introduced Monophyx and Zhutase enzyme blends for broilers and piglets in China.
May 2026: Novonesis; Approval; HiPhorius received full EU label registration, adding laying hens, breeding poultry, piglets and fattening pigs.
Jul 2026: Huvepharma; Acquisition; Signed an agreement to acquire Euroapi Italy, adding about 25% to its fermentation capacity.
Sep 2026: IFF (Danisco Animal Nutrition & Health); Product Launch; Launched Omni-Bos PHY, a phytase for dairy cattle, initially in the Middle East, Africa and Asia Pacific.
Political Factors
Food security policies in China, the Gulf states and India support domestic livestock and feed production.
Trade policies and tariffs on soybean meal and grains influence diet composition and the value of enzymes.
Government programmes to reduce antimicrobial use in animals favour nutritional gut-health solutions.
Economic Factors
Feed grain, soybean meal and feed phosphate price volatility drives demand for cost-saving enzymes.
Rising incomes in emerging economies increase consumption of poultry meat, eggs and pork.
Price competition from low-cost Asian producers compresses margins on standard products.
Social Factors
Consumer preference for antibiotic-free meat and eggs supports enzyme-based gut-health programmes.
Urbanisation shifts demand towards commercially produced, processed animal protein.
Technological Factors
Protein engineering produces more thermostable and faster-acting phytases and carbohydrases.
Near-infrared analysis and digestibility models allow precise assignment of enzyme matrix values.
Liquid post-pellet application systems improve dosing accuracy and enzyme survival.
Environmental Factors
Enzymes reduce phosphorus and nitrogen excretion, supporting compliance with manure and water-quality regulation.
Lower use of mined phosphate and imported soybean meal reduces the environmental footprint of feed.
Legal Factors
Pre-market authorisation and periodic renewal of feed enzymes, notably under Regulation (EC) No 1831/2003.
Restrictions on antibiotic growth promoters in the EU, China and the United States.
Patent protection on enzyme strains and formulations shapes competitive entry.
Profiles of 107 companies operating in the Feed Enzymes Market market, including revenue, employee count, and market positioning where available.
Showing 107 of 107 companies
BASF is the world's largest chemical company by sales, built on the Verbund principle of physically and energetically integrated production sites that turn a handful of feedstocks into thousands of products. Since September 2024 it has run under the "Winning Ways" strategy, which splits the portfolio into four core segments (Chemicals, Materials, Industrial Solutions, Nutrition & Care) that stay integrated, and standalone businesses (Agricultural Solutions, Battery Materials, Environmental Catalyst and Metal Solutions, and the now-divested Coatings) that are being monetized or prepared for capital-market options. In 2025 it generated €59.7 billion in sales and €6.6 billion in EBITDA before special items, a cyclical trough. In 2026 it closed the €7.7 billion Coatings transaction, started up its €-multi-billion Zhanjiang Verbund site, raised earnings guidance, and approached Evonik about a takeover. The investment debate is whether structural cost cuts and portfolio proceeds can restore returns above the cost of capital. --- **The company's own description.** BASF describes its purpose with the line "we create chemistry for a sustainable future" (BASF news release boilerplate, 2026) and states its ambition to be the preferred chemical company for enabling customers' green transformation. It reports around 108,000 employees, customers in nearly every sector and almost every country, and sales of around €60 billion in 2025. The portfolio is described as four core segments plus standalone businesses bundled in Surface Technologies and Agricultural Solutions. **Independent characterization.** BASF is best understood as three businesses under one roof: 1. **An integrated commodity and intermediates engine** (Chemicals, the Monomers half of Materials). This is a steam-cracker-to-derivatives chain selling ethylene and propylene derivatives, isocyanates, polyamide precursors and intermediates on spread economics. Earnings are driven by feedstock and energy costs, operating rates and regional supply-demand. It is the most capital-intensive part of the group and the main source of the 2023–2025 earnings decline: Chemicals EBITDA before special items fell from €1,342 million in 2024 to €853 million in 2025 (Factsheet FY2025). 2. **Formulated and performance products** (Performance Materials, Industrial Solutions, Nutrition & Care). These sell on specification and performance to automotive, construction, packaging, consumer goods, pharma and nutrition customers. Margins are steadier but have come under pressure from Asian competition and, in Care Chemicals, from consumer trading-down to private-label products (Factsheet FY2025 commentary). 3. **Standalone franchises** with different industry logic: Agricultural Solutions (crop protection, seeds and traits, digital farming), ECMS (emissions catalysts plus precious-metal trading and recycling) and Battery Materials. Agricultural Solutions is the group's highest-margin segment at 21.7% EBITDA margin before special items in FY2025 and the largest single earnings contributor at €2,081 million. **Revenue model.** Revenue is almost entirely product sales under supply contracts and spot transactions. There is no subscription model of consequence; digital farming (xarvio) and licensing of process technology and catalysts are small. Seeds and traits include royalty and licensing income within Agricultural Solutions, not separately disclosed. Precious-metal trading inflates ECMS sales (€7,978 million in FY2025) with pass-through metal value, which is why BASF quotes group margins both including and excluding metals (12.3% excluding metals in FY2025 per the CFO on the February 27, 2026 call, versus 11.0% reported). **Value chain position.** Upstream to midstream in petrochemicals with captive crackers at Ludwigshafen, Antwerp, Port Arthur (joint venture with TotalEnergies), Nanjing (joint venture with Sinopec) and Zhanjiang; midstream to downstream in engineering plastics, polyurethane systems, dispersions, additives, surfactants and vitamins; branded and channel-driven in agriculture. BASF exited upstream oil and gas operations when Wintershall Dea's E&P business was transferred to Harbour Energy in September 2024. **Customers and end-markets.** BASF serves industrial customers in chemicals and plastics, transportation, construction, consumer goods, agriculture, electronics, energy and resources, and health and nutrition. Intersegment transfers are large (Chemicals transferred €3,432 million internally in FY2025 on €10,055 million of third-party sales), which shows how much of the upstream output feeds BASF's own downstream chains.
Company Headquarters: Missouri, US Founded: 1991 Workforce: ~800+ Company Working: Novus International manufactures animal health and nutrition products for livestock, poultry, and aquaculture. The products offered by the company include various preservative premixtures, feed supplements, feed additives, nutritional feed acids, chelated trace minerals, feed preservatives, feed antioxidants, and other specialty ingredients. Under its eubiotics products category, the company offers ACIDOMIX, a uniquely formulated blend of organic acids which ensures delivery of its acidification to the lower digestive tract. In addition to its preserving effects, the product has antimicrobial effects that help reduce bacterial contamination levels and energy waste resulting in optimal growth rates. The company has research & development laboratories and manufacturing facilities in more than 35 countries, as well as offices with field staff in an additional 60 countries. Novus International operates as a subsidiary of Mitsui & Co. (U.S.A.) Inc. and Nippon Soda Co., Ltd.
4 interactive charts drawn from the Feed Enzymes Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Feed Enzymes Market By Physical Form
Global Feed Enzymes Market By Livestock
Global Feed Enzymes Market By Enzyme Type
Global Feed Enzymes Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)
